| Bronchial asthma is an air passage chronic inflammation ailment thataeidophilia granular cell, mastcells, T-lymphocytes and so on participatingwith. The inflammation makes susc have air passage altus reactance tovarious kinds of provocative factors, and evokes air passage thickeningandangusty, resulting in dysfunction of ventilation. Clinical manifestationis brupt, recurrent attacks of gasping, anhelation, chest distress and cough.Regularity plexy and tensify at night and/or luce prima. These symptoms canrelieve by themselves or by healing them. There are generous records aboutdenomination, symptoms, etiological factors, pathogenesis and healing ofbronchial asthma In traditional Chinese medical literature, ghu Danxi(Yuandynasty)initiated denomination, elucidated pathogenesis of bronchialasthma-technicality in "tan", drew therapeutic principle-Before bronchialasthma couldn't plexy, we should tonify healthy energy; when bronchialasthma plexied, we should invade evil factor affecting health. The theoryof Traditional Chinese Medicine provided many referred experience andcurative devices. In the literature of modern medicine, there isconsiderable exploration and discussion about definition epidemiology,etiopathogenisis, patho-,degrees of pathogenetic condition and clinicalsymptoms. At present, in the stage of acute episode of bronchial asthma,modern medicine is cardinal device, Traditional Chinese Medicine is minordevice. We should control symptoms and abscise inflammation bylucocorticoid inhalation. In the stage of non-acute episode ofbronchial asthma, in the Tabasis, Traditional Chinese Medicine iscardinal device, it can accommodate eneral immunity function of the patients and obtain better curative effect.Objective: To cure bronchial asthma patients by two devices: buringchords with combination of Shu point and Mu point combined foundationcuring(therapeutic group);foundation curing (control group).we shallanalyze and contrast by curative effect in the near future, long-termcurative effect, pulmonary function indicatrix of prior treatment andpost-treatment, course of treatment, compliance of patients, relapse rateof the two groups, so that we could evaluate curative effect and effectof pulmonary function indicatrix of therapeutic groups preliminarily.Method: According to diagnostic codes, staging standards andstandards of pathogenetic condition graduation that Respiratory MedicineBranch Asthma Group Institute of Medicine of China respiration introduced"Prevention and Curing Companion of Bronchial asthma" in 2003, we shallselect the patients consistent with standards in the out-patient clinic andhospital room of department of acupuncture and moxibustion, hospital room ofrespiration of The First Hospital affiliated Guangzhou University ofChinese Medicine in the periods of February, 2006 and April, 2007. We shalldivide these groups into two groups: therapeutic group in that there are 34patients and control group in that there are 30 patients. Foundation curing:Slow-release Theopylline (Aminophylline Sustained-release Tablets, producedby Guangdong Mai Teyi Xinghua Drug Limited Company), direction:0.1,oral application, twice(mane and vesper)six weeks. Among these two groups,to light press patients, foundation curing is unnecessary. Pro Re Nate,applyingβ2receptor agonist(Ventolin)may be permitted. Severe patients maybreathe in glucocorticosteroid (Becotide). By Chinese crude drug, in theperiod of onset; chilly, caloric and anemo bronchial wheezing symptom-complexpatients deploy distinctly Shegan Mahuang Decoction, Dingchuang Decoctionand Guizhi combined Houpu Xingzi Decoction plus and minus, in the catabasis,pulmonasthenia, splenasthenic syndrome and nephrasthenia syndromesymptom-complex patients deploy distinctly Yupingfeng San, Liujunzi Decoctionand Jinkui Shenqi Wan plus and minus, 1 dosis, being decocted in water for oraldose. Therapeutic group: on the base of foundation curing, we select Feishu,Zhongfu point; Pishu, Zhangmen point; Shenshu Jingmen point, a group per timethree groups are traded-off, per time 1 weeks, twice 1 course of treatment.Control group applies foundation curing. In the stage of therapy, other any medicines besides above-mentioned foundation curing can not be permitted amongthe two groups. After three courses of treatment, we shall observe the curativeeffects and use Pulmonary function Indicatrix, sings and symptoms of riottreatment and post-treatment to evaluate curative effects. By EPI and SPSSstatistics software, we shall undertake statistical analysis, then make theresults undertake group comparison and inner group comparison.Results: The two groups both have better manifestation aboutcurative effect and pulmonary function indicatrix. About curative effect,therapeutic group surpasses control group furthermore(p<0.05), and tolight, midrange bronchial asthma patients in the acute stage and onesintermission state, light and midrange persistence in the catabasis, curativeeffect is good. On pulmonary function indicatrix(FEV1和PEF), therapeuticgroup surpasses control group(FEV1p<0.05, PEFp<0.01); on recurrence andpatients compliance, two groups both have good manifestation.Conclusion: The method of buring chords with combination of Shu point andMu point combined foundation curing can improve pulmonary function ofbronchial asthma patients and promote their clinical control rate andeffective power. To each pathogenetic condition (exept serious and dangerousin the acute period of onset and serious persistence pretherapy), curativeeffects are all good. Besides, this reseach demonstrates that this methodrefers to different sexes and age-layers. In a word, the method of buringchords with combination of Shu point and Mu point combined foundation curingis the reliable and safe one that cures bronchial asthma patients. It hasgood curative effect, small risk, few adverse reaction, low recurrence rateand good compliance, so it has better clinical application value. |